November 24, 2020
Nuvaira Announces Published Two-Year Results in COPD Patients treated with Targeted Lung Denervation
AIRFLOW-2 two-year data confirm sustained reduction of severe COPD exacerbation risk vs. a control group. MINNEAPOLIS, Nov. 23, 2020 /PRNewswire/ — Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, … Continued